Reps have been pounding the pavement for months unlike Vivus. A pathetic launch of "Q" with sluggish sales suggest to me that Doctors are waiting for the safer drug with similar results to hit the market. This is not to mention from Vivus top brass that "Dosing will be complicated and customers can only get from mail order". Doctors have enough headaches and more paperwork is not what they want. Especially given the other benefits of Belviq and similar weight loss results as "Q"
Belviq: Worldwide Sales - On Pharmacy Shelves - Safe - Effective
Setting aside the issues for Q itself, I think the big difference between the launch of Q and Belviq will be Eisai's knowledge and experience at marketing, especially since they have now studied the Q launch and examined why (besides the Q issues) it was such a flop. People who still think Belviq will have a similar launch when it hits the market will be surprisingly WRONG!
And Eisai had an army of well armed reps pounding the pavement just waiting for the word. They're out there anyhow selling other products, so Belviq is just another armor added to their collection of wares.
Sentiment: Strong Buy